- Home
- ICMB vs CNTB Comparison
ICMB vs CNTB Comparison
Compare ICMB & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- CNTB
- Stock Information
- Founded
- ICMB 2012
- CNTB 2012
- Country
- ICMB United States
- CNTB United States
- Employees
- ICMB N/A
- CNTB N/A
- Industry
- ICMB Finance: Consumer Services
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- ICMB Finance
- CNTB Health Care
- Exchange
- ICMB Nasdaq
- CNTB Nasdaq
- Market Cap
- ICMB 41.1M
- CNTB 44.2M
- IPO Year
- ICMB N/A
- CNTB 2021
- Fundamental
- Price
- ICMB $2.75
- CNTB $1.05
- Analyst Decision
- ICMB
- CNTB Strong Buy
- Analyst Count
- ICMB 0
- CNTB 2
- Target Price
- ICMB N/A
- CNTB $7.50
- AVG Volume (30 Days)
- ICMB 25.0K
- CNTB 97.5K
- Earning Date
- ICMB 05-13-2025
- CNTB 05-15-2025
- Dividend Yield
- ICMB 17.27%
- CNTB N/A
- EPS Growth
- ICMB N/A
- CNTB N/A
- EPS
- ICMB 0.82
- CNTB N/A
- Revenue
- ICMB $20,996,189.00
- CNTB $26,033,000.00
- Revenue This Year
- ICMB N/A
- CNTB N/A
- Revenue Next Year
- ICMB N/A
- CNTB N/A
- P/E Ratio
- ICMB $3.37
- CNTB N/A
- Revenue Growth
- ICMB N/A
- CNTB N/A
- 52 Week Low
- ICMB $2.46
- CNTB $0.51
- 52 Week High
- ICMB $3.47
- CNTB $1.63
- Technical
- Relative Strength Index (RSI)
- ICMB 45.17
- CNTB 64.42
- Support Level
- ICMB $2.75
- CNTB $0.91
- Resistance Level
- ICMB $2.95
- CNTB $1.07
- Average True Range (ATR)
- ICMB 0.11
- CNTB 0.09
- MACD
- ICMB -0.00
- CNTB 0.00
- Stochastic Oscillator
- ICMB 18.00
- CNTB 76.47
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.